Report Detail
Global Generic Active Pharmaceutical Ingredients Market Insights, Forecast to 2025
- RnM2910842 |
- 08 February, 2019 |
- Global |
- 114 Pages |
- QYResearch |
- Pharma & Healthcare
The global Generic Active Pharmaceutical Ingredients market is valued at million US$ in 2018 and will reach million US$ by the end of 2025, growing at a CAGR of during 2019-2025. The objectives of this study are to define, segment, and project the size of the Generic Active Pharmaceutical Ingredients market based on company, product type, end user and key regions.
This report studies the global market size of Generic Active Pharmaceutical Ingredients in key regions like North America, Europe, Asia Pacific, Central & South America and Middle East & Africa, focuses on the consumption of Generic Active Pharmaceutical Ingredients in these regions.
This research report categorizes the global Generic Active Pharmaceutical Ingredients market by top players/brands, region, type and end user. This report also studies the global Generic Active Pharmaceutical Ingredients market status, competition landscape, market share, growth rate, future trends, market drivers, opportunities and challenges, sales channels and distributors.
The following manufacturers are covered in this report, with sales, revenue, market share for each company:
Pfizer, Inc. (U.S.)
Novartis International AG (Switzerland)
Sanofi (France)
Boehringer Ingelheim (Germany)
Bristol-Myers Squibb (U.S.)
Teva Pharmaceutical Industries Ltd. (Israel)
Eli Lilly and Company (U.S.)
GlaxoSmithKline plc (U.K.)
Merck & Co., Inc. (U.S.)
AbbVie Inc. (U.S.)
Market size by Product
Monoclonal Antibodies
Hormones
Cytokines
Fusion Proteins
Therapeutic Enzymes
Vaccines
Blood Factors
Market size by End User
Oncology
Diabetes
Cardiovascular Disease
CNS and Neurological Disorders
Endocrinology
Others
Market size by Region
North America
United States
Canada
Mexico
Asia-Pacific
China
India
Japan
South Korea
Australia
Indonesia
Singapore
Malaysia
Philippines
Thailand
Vietnam
Europe
Germany
France
UK
Italy
Spain
Russia
Central & South America
Brazil
Rest of Central & South America
Middle East & Africa
GCC Countries
Turkey
Egypt
South Africa
The study objectives of this report are:
To study and analyze the global Generic Active Pharmaceutical Ingredients market size (value & volume) by company, key regions, products and end user, breakdown data from 2014 to 2018, and forecast to 2025.
To understand the structure of Generic Active Pharmaceutical Ingredients market by identifying its various subsegments.
To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges and risks).
Focuses on the key global Generic Active Pharmaceutical Ingredients companies, to define, describe and analyze the sales volume, value, market share, market competition landscape and recent development.
To project the value and sales volume of Generic Active Pharmaceutical Ingredients submarkets, with respect to key regions.
To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
In this study, the years considered to estimate the market size of Generic Active Pharmaceutical Ingredients are as follows:
History Year: 2014-2018
Base Year: 2018
Estimated Year: 2019
Forecast Year 2019 to 2025
This report includes the estimation of market size for value (million US$) and volume (K MT). Both top-down and bottom-up approaches have been used to estimate and validate the market size of Generic Active Pharmaceutical Ingredients market, to estimate the size of various other dependent submarkets in the overall market. Key players in the market have been identified through secondary research, and their market shares have been determined through primary and secondary research. All percentage shares, splits, and breakdowns have been determined using secondary sources and verified primary sources.
For the data information by region, company, type and application, 2018 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.
Table of Contents
1 Study Coverage
- 1.1 Generic Active Pharmaceutical Ingredients Product
- 1.2 Market Segments
- 1.3 Key Manufacturers Covered
- 1.4 Market by Type
- 1.4.1 Global Generic Active Pharmaceutical Ingredients Market Size Growth Rate by Product
- 1.4.2 Monoclonal Antibodies
- 1.4.3 Hormones
- 1.4.4 Cytokines
- 1.4.5 Fusion Proteins
- 1.4.6 Therapeutic Enzymes
- 1.4.7 Vaccines
- 1.4.8 Blood Factors
- 1.5 Market by End User
- 1.5.1 Global Generic Active Pharmaceutical Ingredients Market Size Growth Rate by End User
- 1.5.2 Oncology
- 1.5.3 Diabetes
- 1.5.4 Cardiovascular Disease
- 1.5.5 CNS and Neurological Disorders
- 1.5.6 Endocrinology
- 1.5.7 Others
- 1.6 Study Objectives
- 1.7 Years Considered
2 Executive Summary
- 2.1 Global Generic Active Pharmaceutical Ingredients Market Size
- 2.1.1 Global Generic Active Pharmaceutical Ingredients Revenue 2014-2025
- 2.1.2 Global Generic Active Pharmaceutical Ingredients Sales 2014-2025
- 2.2 Generic Active Pharmaceutical Ingredients Growth Rate by Regions
- 2.2.1 Global Generic Active Pharmaceutical Ingredients Sales by Regions
- 2.2.2 Global Generic Active Pharmaceutical Ingredients Revenue by Regions
3 Breakdown Data by Manufacturers
- 3.1 Generic Active Pharmaceutical Ingredients Sales by Manufacturers
- 3.1.1 Generic Active Pharmaceutical Ingredients Sales by Manufacturers
- 3.1.2 Generic Active Pharmaceutical Ingredients Sales Market Share by Manufacturers
- 3.1.3 Global Generic Active Pharmaceutical Ingredients Market Concentration Ratio (CR5 and HHI)
- 3.2 Generic Active Pharmaceutical Ingredients Revenue by Manufacturers
- 3.2.1 Generic Active Pharmaceutical Ingredients Revenue by Manufacturers (2014-2019)
- 3.2.2 Generic Active Pharmaceutical Ingredients Revenue Share by Manufacturers (2014-2019)
- 3.3 Generic Active Pharmaceutical Ingredients Price by Manufacturers
- 3.4 Generic Active Pharmaceutical Ingredients Manufacturing Base Distribution, Product Types
- 3.4.1 Generic Active Pharmaceutical Ingredients Manufacturers Manufacturing Base Distribution, Headquarters
- 3.4.2 Manufacturers Generic Active Pharmaceutical Ingredients Product Type
- 3.4.3 Date of International Manufacturers Enter into Generic Active Pharmaceutical Ingredients Market
- 3.5 Manufacturers Mergers & Acquisitions, Expansion Plans
4 Breakdown Data by Product
- 4.1 Global Generic Active Pharmaceutical Ingredients Sales by Product
- 4.2 Global Generic Active Pharmaceutical Ingredients Revenue by Product
- 4.3 Generic Active Pharmaceutical Ingredients Price by Product
5 Breakdown Data by End User
- 5.1 Overview
- 5.2 Global Generic Active Pharmaceutical Ingredients Breakdown Data by End User
6 North America
- 6.1 North America Generic Active Pharmaceutical Ingredients by Countries
- 6.1.1 North America Generic Active Pharmaceutical Ingredients Sales by Countries
- 6.1.2 North America Generic Active Pharmaceutical Ingredients Revenue by Countries
- 6.1.3 United States
- 6.1.4 Canada
- 6.1.5 Mexico
- 6.2 North America Generic Active Pharmaceutical Ingredients by Product
- 6.3 North America Generic Active Pharmaceutical Ingredients by End User
7 Europe
- 7.1 Europe Generic Active Pharmaceutical Ingredients by Countries
- 7.1.1 Europe Generic Active Pharmaceutical Ingredients Sales by Countries
- 7.1.2 Europe Generic Active Pharmaceutical Ingredients Revenue by Countries
- 7.1.3 Germany
- 7.1.4 France
- 7.1.5 UK
- 7.1.6 Italy
- 7.1.7 Russia
- 7.2 Europe Generic Active Pharmaceutical Ingredients by Product
- 7.3 Europe Generic Active Pharmaceutical Ingredients by End User
8 Asia Pacific
- 8.1 Asia Pacific Generic Active Pharmaceutical Ingredients by Countries
- 8.1.1 Asia Pacific Generic Active Pharmaceutical Ingredients Sales by Countries
- 8.1.2 Asia Pacific Generic Active Pharmaceutical Ingredients Revenue by Countries
- 8.1.3 China
- 8.1.4 Japan
- 8.1.5 Korea
- 8.1.6 India
- 8.1.7 Australia
- 8.1.8 Indonesia
- 8.1.9 Malaysia
- 8.1.10 Philippines
- 8.1.11 Thailand
- 8.1.12 Vietnam
- 8.1.13 Singapore
- 8.2 Asia Pacific Generic Active Pharmaceutical Ingredients by Product
- 8.3 Asia Pacific Generic Active Pharmaceutical Ingredients by End User
9 Central & South America
- 9.1 Central & South America Generic Active Pharmaceutical Ingredients by Countries
- 9.1.1 Central & South America Generic Active Pharmaceutical Ingredients Sales by Countries
- 9.1.2 Central & South America Generic Active Pharmaceutical Ingredients Revenue by Countries
- 9.1.3 Brazil
- 9.2 Central & South America Generic Active Pharmaceutical Ingredients by Product
- 9.3 Central & South America Generic Active Pharmaceutical Ingredients by End User
10 Middle East and Africa
- 10.1 Middle East and Africa Generic Active Pharmaceutical Ingredients by Countries
- 10.1.1 Middle East and Africa Generic Active Pharmaceutical Ingredients Sales by Countries
- 10.1.2 Middle East and Africa Generic Active Pharmaceutical Ingredients Revenue by Countries
- 10.1.3 GCC Countries
- 10.1.4 Turkey
- 10.1.5 Egypt
- 10.1.6 South Africa
- 10.2 Middle East and Africa Generic Active Pharmaceutical Ingredients by Product
- 10.3 Middle East and Africa Generic Active Pharmaceutical Ingredients by End User
11 Company Profiles
- 11.1 Pfizer, Inc. (U.S.)
- 11.1.1 Pfizer, Inc. (U.S.) Company Details
- 11.1.2 Company Business Overview
- 11.1.3 Pfizer, Inc. (U.S.) Generic Active Pharmaceutical Ingredients Sales, Revenue and Gross Margin (2014-2019)
- 11.1.4 Pfizer, Inc. (U.S.) Generic Active Pharmaceutical Ingredients Products Offered
- 11.1.5 Pfizer, Inc. (U.S.) Recent Development
- 11.2 Novartis International AG (Switzerland)
- 11.2.1 Novartis International AG (Switzerland) Company Details
- 11.2.2 Company Business Overview
- 11.2.3 Novartis International AG (Switzerland) Generic Active Pharmaceutical Ingredients Sales, Revenue and Gross Margin (2014-2019)
- 11.2.4 Novartis International AG (Switzerland) Generic Active Pharmaceutical Ingredients Products Offered
- 11.2.5 Novartis International AG (Switzerland) Recent Development
- 11.3 Sanofi (France)
- 11.3.1 Sanofi (France) Company Details
- 11.3.2 Company Business Overview
- 11.3.3 Sanofi (France) Generic Active Pharmaceutical Ingredients Sales, Revenue and Gross Margin (2014-2019)
- 11.3.4 Sanofi (France) Generic Active Pharmaceutical Ingredients Products Offered
- 11.3.5 Sanofi (France) Recent Development
- 11.4 Boehringer Ingelheim (Germany)
- 11.4.1 Boehringer Ingelheim (Germany) Company Details
- 11.4.2 Company Business Overview
- 11.4.3 Boehringer Ingelheim (Germany) Generic Active Pharmaceutical Ingredients Sales, Revenue and Gross Margin (2014-2019)
- 11.4.4 Boehringer Ingelheim (Germany) Generic Active Pharmaceutical Ingredients Products Offered
- 11.4.5 Boehringer Ingelheim (Germany) Recent Development
- 11.5 Bristol-Myers Squibb (U.S.)
- 11.5.1 Bristol-Myers Squibb (U.S.) Company Details
- 11.5.2 Company Business Overview
- 11.5.3 Bristol-Myers Squibb (U.S.) Generic Active Pharmaceutical Ingredients Sales, Revenue and Gross Margin (2014-2019)
- 11.5.4 Bristol-Myers Squibb (U.S.) Generic Active Pharmaceutical Ingredients Products Offered
- 11.5.5 Bristol-Myers Squibb (U.S.) Recent Development
- 11.6 Teva Pharmaceutical Industries Ltd. (Israel)
- 11.6.1 Teva Pharmaceutical Industries Ltd. (Israel) Company Details
- 11.6.2 Company Business Overview
- 11.6.3 Teva Pharmaceutical Industries Ltd. (Israel) Generic Active Pharmaceutical Ingredients Sales, Revenue and Gross Margin (2014-2019)
- 11.6.4 Teva Pharmaceutical Industries Ltd. (Israel) Generic Active Pharmaceutical Ingredients Products Offered
- 11.6.5 Teva Pharmaceutical Industries Ltd. (Israel) Recent Development
- 11.7 Eli Lilly and Company (U.S.)
- 11.7.1 Eli Lilly and Company (U.S.) Company Details
- 11.7.2 Company Business Overview
- 11.7.3 Eli Lilly and Company (U.S.) Generic Active Pharmaceutical Ingredients Sales, Revenue and Gross Margin (2014-2019)
- 11.7.4 Eli Lilly and Company (U.S.) Generic Active Pharmaceutical Ingredients Products Offered
- 11.7.5 Eli Lilly and Company (U.S.) Recent Development
- 11.8 GlaxoSmithKline plc (U.K.)
- 11.8.1 GlaxoSmithKline plc (U.K.) Company Details
- 11.8.2 Company Business Overview
- 11.8.3 GlaxoSmithKline plc (U.K.) Generic Active Pharmaceutical Ingredients Sales, Revenue and Gross Margin (2014-2019)
- 11.8.4 GlaxoSmithKline plc (U.K.) Generic Active Pharmaceutical Ingredients Products Offered
- 11.8.5 GlaxoSmithKline plc (U.K.) Recent Development
- 11.9 Merck & Co., Inc. (U.S.)
- 11.9.1 Merck & Co., Inc. (U.S.) Company Details
- 11.9.2 Company Business Overview
- 11.9.3 Merck & Co., Inc. (U.S.) Generic Active Pharmaceutical Ingredients Sales, Revenue and Gross Margin (2014-2019)
- 11.9.4 Merck & Co., Inc. (U.S.) Generic Active Pharmaceutical Ingredients Products Offered
- 11.9.5 Merck & Co., Inc. (U.S.) Recent Development
- 11.10 AbbVie Inc. (U.S.)
- 11.10.1 AbbVie Inc. (U.S.) Company Details
- 11.10.2 Company Business Overview
- 11.10.3 AbbVie Inc. (U.S.) Generic Active Pharmaceutical Ingredients Sales, Revenue and Gross Margin (2014-2019)
- 11.10.4 AbbVie Inc. (U.S.) Generic Active Pharmaceutical Ingredients Products Offered
- 11.10.5 AbbVie Inc. (U.S.) Recent Development
12 Future Forecast
- 12.1 Generic Active Pharmaceutical Ingredients Market Forecast by Regions
- 12.1.1 Global Generic Active Pharmaceutical Ingredients Sales Forecast by Regions 2019-2025
- 12.1.2 Global Generic Active Pharmaceutical Ingredients Revenue Forecast by Regions 2019-2025
- 12.2 Generic Active Pharmaceutical Ingredients Market Forecast by Product
- 12.2.1 Global Generic Active Pharmaceutical Ingredients Sales Forecast by Product 2019-2025
- 12.2.2 Global Generic Active Pharmaceutical Ingredients Revenue Forecast by Product 2019-2025
- 12.3 Generic Active Pharmaceutical Ingredients Market Forecast by End User
- 12.4 North America Generic Active Pharmaceutical Ingredients Forecast
- 12.5 Europe Generic Active Pharmaceutical Ingredients Forecast
- 12.6 Asia Pacific Generic Active Pharmaceutical Ingredients Forecast
- 12.7 Central & South America Generic Active Pharmaceutical Ingredients Forecast
- 12.8 Middle East and Africa Generic Active Pharmaceutical Ingredients Forecast
13 Market Opportunities, Challenges, Risks and Influences Factors Analysis
- 13.1 Market Opportunities and Drivers
- 13.2 Market Challenges
- 13.3 Market Risks/Restraints
- 13.4 Macroscopic Indicators
14 Value Chain and Sales Channels Analysis
- 14.1 Value Chain Analysis
- 14.2 Generic Active Pharmaceutical Ingredients Customers
- 14.3 Sales Channels Analysis
- 14.3.1 Sales Channels
- 14.3.2 Distributors
15 Research Findings and Conclusion
16 Appendix
- 16.1 Research Methodology
- 16.1.1 Methodology/Research Approach
- 16.1.2 Data Source
- 16.2 Author Details
Summary:
Get latest Market Research Reports on Generic Active Pharmaceutical Ingredients . Industry analysis & Market Report on Generic Active Pharmaceutical Ingredients is a syndicated market report, published as Global Generic Active Pharmaceutical Ingredients Market Insights, Forecast to 2025. It is complete Research Study and Industry Analysis of Generic Active Pharmaceutical Ingredients market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.
REPORT YOU MIGHT BE INTERESTED
Related Reports
Reason to Buy
Reports and Markets
Contact Us
+1-352-353-0818 (US)Newsletter
KEEP UP TO DATE ON ALL THE LATEST REPORTS
